AB InBev would sell at "very low" prices or even give away the spent grains left over from the brewing process that could be converted to protein to help address increasing global food and sustainability challenges,
After three years working with AB InBev, the startup EverGrain has developed ingredients used in protein shakes and bars, bread, and barley milk.
With a new factory slated to open in St. Louis in March, AB InBev says expects EverGrain to haul in $20 million next year.
ZX Ventures is also hoping to leverage AB InBev's fermentation knowledge to scale up the production of alternative proteins through its company BioBrew.
Bernardo Novick, the global head of the AB InBev incubator ZX Ventures, emphasized that no one in the world possesses as much scaled fermentation knowledge as ABI. He added that the application of biotechnology to food and beverage is expected to be a massive opportunity in the next 10 to 20 years.
He noted that the market for alternative fermented protein alone is estimated to reach $22 billion by 2035.
But Novick admitted that BioBrew is still in exploratory spaces as to the kinds of products it could produce.
According to AB InBev CEO Michel Doukeris, the company pledged to combine its brewing infrastructure and expertise with biotech advancements to help address increasing global food and sustainability challenges.
He added that the company can leverage its core brewing and fermentation capabilities in new and exciting ways.
AB InBev expects $57 billion in sales for 2022.


Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election
Fungi are among the planet’s most important organisms — yet they continue to be overlooked in conservation strategies
How America courted increasingly destructive wildfires − and what that means for protecting homes today
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Burkina Faso and Mali’s fabulous flora: new plant life record released
How is Antarctica melting, exactly? Crucial details are beginning to come into focus
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
We combed through old botanical surveys to track how plants on Australia’s islands are changing
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices
Fertile land for growing vegetables is at risk — but a scientific discovery could turn the tide
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
UK Starting Salaries See Strongest Growth in 18 Months as Hiring Sentiment Improves
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record
Australian Household Spending Dips in December as RBA Tightens Policy
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances 



